Gene: ZNF621
Official Full Name: zinc finger protein 621provided by HGNC
Gene Summary: Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be located in nucleus. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO12106 | ZNF621 Knockout cell line (HeLa) | Human | ZNF621 | 1:3~1:6 | Negative | Online Inquiry |
KO12107 | ZNF621 Knockout cell line (HCT 116) | Human | ZNF621 | 1:2~1:4 | Negative | Online Inquiry |
KO12108 | ZNF621 Knockout cell line (HEK293) | Human | ZNF621 | 1:3~1:6 | Negative | Online Inquiry |
KO12109 | ZNF621 Knockout cell line (A549) | Human | ZNF621 | 1:3~1:4 | Negative | Online Inquiry |
ZNF621 Gene Knockout Cell Lines are expertly engineered cellular models where the ZNF621 gene has been selectively disabled. This gene is significant in various physiological processes, including gene regulation and cellular differentiation. By utilizing CRISPR-Cas9 gene-editing technology, our ZNF621 Knockout Cell Lines provide researchers with a powerful tool to investigate the functional roles of this gene, allowing detailed studies of its contributions to disease mechanisms and potential drug responses.
These knockout cell lines operate through a precise disruption of the ZNF621 gene, resulting in the loss of its associated protein product. This enables a clearer understanding of the gene's role in key biological pathways, with a focus on cell proliferation, apoptosis, and stress response mechanisms. Scientists can leverage these models to conduct experiments that elucidate the gene's involvement in conditions such as cancer, neurodegenerative diseases, and metabolic disorders.
The scientific importance of these cell lines lies in their ability to facilitate investigations in both research and clinical settings, particularly in gene therapy, regenerative medicine, and pharmacogenomics. By providing insights into ZNF621's function, researchers can develop targeted therapies that address specific dysfunctions associated with this gene, enhancing personalized medicine approaches.
Distinctly, our ZNF621 Gene Knockout Cell Lines offer several advantages over traditional models, including higher specificity and reproducibility in experiments. Unlike other gene-editing technologies that may lead to off-target effects, our meticulously validated knockout lines ensure accurate gene disruption without unintended alterations, making them a dependable platform for research.
These cell lines are invaluable to researchers and clinicians alike, empowering them with the necessary tools to push the boundaries of molecular biology and therapeutic development. Our commitment to quality and innovation ensures that you receive a product backed by extensive expertise in gene editing and cellular biology.
As a leader in biological product development, our company combines cutting-edge technology with a deep understanding of scientific intricacies, ensuring our products meet the highest research standards. By choosing our ZNF621 Gene Knockout Cell Lines, you join a community dedicated to advancing biological science and improving health outcomes.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.